Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department
Clinical trial NCT07726069 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07726069
- Sponsor
- University of Illinois at Chicago
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-01
- Primary completion
- 2028-01-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.